Vaccine microarray patch self-administration: A preliminary study in adults 50 years of age and over

• Published in: Vaccine Vol. 48; p. 126699
• Main Authors: Davies, C., Baker, B., Berger, M.N., Knox, S.L., Mowbray, E., Stewart, B.G., Booy, R., Hacker, E., Marmol, A., Ross, C., Muller, D.A., Mortimore, A.M., Siller, G., Forster, A.H., Skinner, S.R.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 27.02.2025; Elsevier Limited
• Subjects: Acceptability; Adults; Aged; Aged, 80 and over; Allergy and Immunology; applicators; arms (limbs); Australia; Consent; Cost control; descriptive statistics; Effectiveness; Female; females; Fluorescence; High-density microarray patch; Humans; Immunization; Influenza; intramuscular injection; Male; males; Microarray patch; microarray technology; Middle Aged; Older adults; Older people; Patient Acceptance of Health Care; Qualitative research; Safety; Self Administration - methods; Self-administration; Selfadministration; Skin; Software; Statistical analysis; surveys; Transdermal Patch; Usability; Vaccination; Vaccination - methods; Vaccine; Vaccines; Vaccines - administration & dosage; Water loss; Australia; Queensland Australia; Germany; TEWL; High-density microarray patch; Vaccination; Vaccine; UA; Older adults; Acceptability; Microarray patch; Selfadministration; IFU; Adults; Safety; HD-MAP; FA; Usability; MAP; Instructions for use; Transepidermal water loss; Volar forearm; High-Density Micorarry Patch; Upper arm

We assessed the safety, performance, acceptability, and usability of the High-Density Microarray Patch (HD-MAP) for vaccination in adults aged 50 and over. This study was a single-centre, open-label, single-arm intervention in healthy adults aged 50+. HD-MAPs (vaccine-free) were applied by a trained...